AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
AlgaeCytes Limited has developed a proven innovative approach to the production of Omega 3 fatty acids, which are polyunsaturated fatty acids used in numerous bodily functions, such as controlling blood clotting and building cell membranes in the brain. Associated with many health benefits, including protection against heart disease and possibly stroke, new studies are identifying potential benefits for a wide range of conditions including cancer, inflammatory bowel disease and other auto-immune diseases such as lupus and rheumatoid arthritis.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 14, 2022 | Series Unknown | €5M | 1 | IBG Risikokapitalfonds II GmbH & Co. KG | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
IBG Risikokapitalfonds II GmbH & Co. KG | Yes | Series Unknown |